AmoyDx® FGFR1-4 NGS Panel
Detection of mutations and fusions in the FGFR1, FGFR2, FGFR3 and FGFR4 genes
Detection of mutations and fusions in the FGFR1, FGFR2, FGFR3 and FGFR4 genes
Breast cancer is one of the most common cancers in women worldwide. In Germany, every 8th woman is diagnosed with breast cancer. Until now, therapies have been based on the presence/absence of (hormone) receptors or the Her2 receptor in metastatic/non-metastatic breast cancer.
Anhaltinerstraße 16
14163 Berlin
+49 30-804 984 990
+49 30-804 984 999
info@zytomed-systems.de
Intensive consulting and individual support. Anytime and anywhere.
Customer Support
030-804 984 990
Technical support
+49 30-23 59 67 500
Currently, we do not have the capacity to produce customized antibodies. We are happy to put you in touch with reliable partners. You can contact us via phone +49 30 804 984 990 or via mail to info@zytomed-systems.de.
IThe technical datasheet of every antibody lists the tested reactivity of the antibody. This does not mean that the antibody does not react with species not listed, but that they have not been verified. If the desired reactivity of the antibody is not listed, please contact us via phone +49 30 804 984 990 or via mail to info@zytomed-systems.de. We are happy to check if the antibody is suitable for your application.
Delivery is on account and at the costs of the purchaser.
The delivery time for our products is about 5 to 15 days.
A mercury-vapor lamp (100 Watt) is optimally suited for FISH.
